Hing C. Wong, Chief Executive Officer, 10% Owner at HCW Biologics Inc. (HCWB), bought 23,210 shares at $2.58 ($60K) on 2026-07-29, disclosed to the SEC on 2026-07-31.
CEO Hing C. Wong purchased 23,210 shares for $59,998 on July 29, 2026, marking the largest insider purchase in the company's history. This significant buyback by the CEO, occurring after a period of consecutive selling, suggests high conviction in the stock's recovery potential.
The stock has experienced extreme volatility, surging 631.92% over the last 90 days to reach $3.29, though it remains down 22.41% year-to-date and is trading 55.24% below its 52-week high of $7.35.
1) The CEO's purchase is the largest insider buy in company history, signaling strong conviction in the turnaround narrative. 2) The stock has surged 631.92% over the last 90 days, potentially setting the stage for a reversion to the mean or continued momentum if fundamentals support the run-up.
1) The stock is trading 55.24% below its 52-week high of $7.35, indicating significant room for downside if the recent rally falters. 2) The company has a forward P/E of -4.87, suggesting fundamental losses that may not be reflected in the current price action.
Something here stands out, but not much.
| Filing → |
| HCWB | BUY | 2025-05-09 | $2.4M | — | Filing → |
| HCWB | BUY | 2023-09-18 | $4K | — | Filing → |
| HCWB | BUY | 2023-06-02 | $3K | — | Filing → |